Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05331664
PHASE4

Dropless Pars Plana Vitrectomy Study

Sponsor: Massachusetts Eye and Ear Infirmary

View on ClinicalTrials.gov

Summary

To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

168

Start Date

2022-07-25

Completion Date

2027-01-30

Last Updated

2025-06-25

Healthy Volunteers

Yes

Interventions

PROCEDURE

Pars plana vitrectomy

Standard of care surgery

DRUG

Triamcinolone Acetonide 40mg/mL

Sub-tenon injection of triamcinolone acetonide (40mg/mL) at the time of surgery

DRUG

Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin

Antibiotic eye drop 4 times per day for 1 week after surgery

DRUG

Prednisolone 1%

Steroid eye drop 4 times per day tapered by one drop weekly for 4 weeks (4/3/2/1 taper) after surgery

DRUG

Atropine 1%

Eye drop daily for 1 week after surgery

Locations (1)

Massachusetts Eye and Ear

Boston, Massachusetts, United States